![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 26, 2018 10:48:54 AM
We have the back-end of financing that will allow us to raise a lot off money. I think currently just over 100 million in financing from Aspire and the shelf. However Aspire at .70 is not a good option for shareholders to tap the remaining 28 million. I agree. I believe that is why the share price does not move mountains on very positive results. Because in the back of every possible investor....when can IPIX make the jump and have the $ and resources to move many trials forward and allow the positive results to make huge MC gains? Bring the valuation to a true value!
That is when we can stop the drip and have institutional support on the stock. There will forever be shorts. We can agree, and that is good. But we need a healthy percentage of the 140 million in real long term investors hands..Baker bros etc...
My gut and to answer your question: I believe Art and Leo have their suitor. I believe they have been working with this pharma for a very long time. I believe that IPIX has made it clear on their goals and valuation proposals and those were no way in hell going to be met prior to receiving Up and OM data. But now the data is in. Now they can move forward and sign the dotted line, IMO.
My real concern is that new interested parties have come into the picture and may derail some of the long term work that IPIX and suitor 1 have accomplished over the past 2-3 years.
But competition is great and makes people move. It can also increase value in biotech...so let’s hope by Leo stating more people are interested in an already ROBUST audience is a good thing
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM